Eli Lily

GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Fri, 07/26/24 - 11:03 am
obesity
weight loss
GLP-1 agonist
healthcare costs
Eli Lily
Novo Nordisk
Wegovy
Zepbound
Ibrance trial failure dashes Pfizer’s growth hopes for the drug
Pharmaforum
Sun, 10/11/20 - 10:23 pm
Pfizer
Ibrance
breast cancer
Eli Lily
Verzenio
Fierce Competition in the Diabetes Drug Market
Motley Fool
Sun, 02/2/14 - 11:36 am
diabetes
GSK
Sanofi
Astra Zeneca
Bristol-Myers Squibb
Novo Nordisk
Eli Lily
Takeda
Eli Lilly's Big Bet On Diabetes
Seeking Alpha
Tue, 04/23/13 - 07:54 am
Eli Lily
diabetes
insulin
LY2605541
dulaglutide
LY2963016
empagliflozin